PROSTATE CANCER

Prostate cancer gene from the loss, it is pathological in Shanxi Tumor Hospital director Wang Hung-wide applications such as microdissection, from the level of gene detection of prostate cancer origin concluded.

Prostate cancer in cancer mortality in men, lung cancer has been beyond the second one. Because the disease is a combination of multiple genes changed tumor, pathological changes and the clinical performance of a variety show, according to morphology and cell carcinoma lesions of the reasons for the judgment of the traditional methods highly inaccurate, often leads to the treatment of the blind, affecting prognosis.